Trial intelligence / Profile preview

Effectiveness of Curcumin in Patients With Parkinson's Disease

IRCT20171123037600N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
May 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of curcumin in Parkinson's disease (PD), sponsored by Mashhad University of Medical Sciences. Started May 2018; status: completed.

02

Drugs

curcumin
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on IRCT20171123037600N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171123037600N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call